147 related articles for article (PubMed ID: 17713475)
21. Expression of IMPDH1 and IMPDH2 after transplantation and initiation of immunosuppression.
Bremer S; Mandla R; Vethe NT; Rasmussen I; Rootwelt H; Line PD; Midtvedt K; Bergan S
Transplantation; 2008 Jan; 85(1):55-61. PubMed ID: 18192912
[TBL] [Abstract][Full Text] [Related]
22. Recipient pretransplant inosine monophosphate dehydrogenase activity in nonmyeloablative hematopoietic cell transplantation.
Bemer MJ; Risler LJ; Phillips BR; Wang J; Storer BE; Sandmaier BM; Duan H; Raccor BS; Boeckh MJ; McCune JS
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1544-52. PubMed ID: 24923537
[TBL] [Abstract][Full Text] [Related]
23. Effect of mycophenolate mofetil monotherapy on T-cell functions and inosine monophosphate dehydrogenase activity in patients undergoing a kidney transplantation.
Kamar N; Glander P; Nolting J; Böhler T; Hambach P; Liefeldt L; Neumayer HH; Klupp J; Budde K
Transplant Proc; 2006 Sep; 38(7):2292-4. PubMed ID: 16980068
[TBL] [Abstract][Full Text] [Related]
24. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.
Budde K; Glander P; Krämer BK; Fischer W; Hoffmann U; Bauer S; Grohmann J; Neumayer HH; Arns W
Transplantation; 2007 Feb; 83(4):417-24. PubMed ID: 17318074
[TBL] [Abstract][Full Text] [Related]
25. Inosine monophosphate dehydrogenase activity in paediatrics: age-related regulation and response to mycophenolic acid.
Rother A; Glander P; Vitt E; Czock D; von Ahsen N; Armstrong VW; Oellerich M; Budde K; Feneberg R; Tönshoff B; Weber LT
Eur J Clin Pharmacol; 2012 Jun; 68(6):913-22. PubMed ID: 22274404
[TBL] [Abstract][Full Text] [Related]
26. High interpatient variability in response to mycophenolic acid maintenance therapy in patients with ANCA-associated vasculitis.
Schaier M; Scholl C; Scharpf D; Schmitt WH; Schwenger V; Zeier M; Sommerer C
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i138-45. PubMed ID: 25805745
[TBL] [Abstract][Full Text] [Related]
27. Customized mycophenolate dosing based on measuring inosine-monophosphate dehydrogenase activity significantly improves patients' outcomes after renal transplantation.
Raggi MC; Siebert SB; Steimer W; Schuster T; Stangl MJ; Abendroth DK
Transplantation; 2010 Dec; 90(12):1536-41. PubMed ID: 21076373
[TBL] [Abstract][Full Text] [Related]
28. Mycophenolate pharmacokinetics and inosine monophosphate dehydrogenase activity in liver transplant recipients with an emphasis on therapeutic drug monitoring.
Reine PA; Vethe NT; Kongsgaard UE; Andersen AM; Line PD; Ali AM; Bergan S
Scand J Clin Lab Invest; 2013 Mar; 73(2):117-24. PubMed ID: 23281843
[TBL] [Abstract][Full Text] [Related]
29. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
Behrend M
Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667
[TBL] [Abstract][Full Text] [Related]
30. Optimization and application of an HPLC method for quantification of inosine-5'-monophosphate dehydrogenase activity as a pharmacodynamic biomarker of mycophenolic acid in Chinese renal transplant patients.
Liu F; Xu L; Sheng C; Qiu X; Zhang M; Jiao Z
Clin Chim Acta; 2018 Oct; 485():333-339. PubMed ID: 29964005
[TBL] [Abstract][Full Text] [Related]
31. Effect of mycophenolic acid on inosine monophosphate dehydrogenase (IMPDH) activity in liver transplant patients.
Neuberger M; Sommerer C; Böhnisch S; Metzendorf N; Mehrabi A; Stremmel W; Gotthardt D; Zeier M; Weiss KH; Rupp C
Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):543-550. PubMed ID: 31924555
[TBL] [Abstract][Full Text] [Related]
32. Plasma and intracellular pharmacokinetic-pharmacodynamic analysis of mycophenolic acid in de novo kidney transplant patients.
Thi MT; Mourad M; Capron A; Tshinanu FM; Vincent MF; Wallemacq P
Clin Biochem; 2015 Apr; 48(6):401-5. PubMed ID: 25523299
[TBL] [Abstract][Full Text] [Related]
33. Mycophenolate mofetil: suggested guidelines for use in kidney transplantation.
Behrend M
BioDrugs; 2001; 15(1):37-53. PubMed ID: 11437674
[TBL] [Abstract][Full Text] [Related]
34. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients.
Langman LJ; LeGatt DF; Halloran PF; Yatscoff RW
Transplantation; 1996 Sep; 62(5):666-72. PubMed ID: 8830834
[TBL] [Abstract][Full Text] [Related]
35. Non-radioactive determination of inosine 5'-monophosphate dehydro-genase (IMPDH) in peripheral mononuclear cells.
Glander P; Braun KP; Hambach P; Bauer S; Mai I; Roots I; Waiser J; Fritsche L; Neumayer HH; Budde K
Clin Biochem; 2001 Oct; 34(7):543-9. PubMed ID: 11738390
[TBL] [Abstract][Full Text] [Related]
36. Activation of the purine salvage pathway in mononuclear cells of cardiac recipients treated with mycophenolate mofetil.
Devyatko E; Zuckermann A; Bohdjalian A; Roedler S; Dunkler D; Grimm M; Weigel G
Transplantation; 2006 Jul; 82(1):113-8. PubMed ID: 16861950
[TBL] [Abstract][Full Text] [Related]
37. Assessment of mycophenolic acid-induced immunosuppression: a new approach.
Millan O; Oppenheimer F; Brunet M; Vilardell J; Rojo I; Vives J; Martorell J
Clin Chem; 2000 Sep; 46(9):1376-83. PubMed ID: 10973868
[TBL] [Abstract][Full Text] [Related]
38. Expression of IMPDH1 is regulated in response to mycophenolate concentration.
Bremer S; Vethe NT; Rootwelt H; Bergan S
Int Immunopharmacol; 2009 Feb; 9(2):173-80. PubMed ID: 19010451
[TBL] [Abstract][Full Text] [Related]
39. Mycophenolate mofetil treatment following renal transplantation decreases GTP concentrations in mononuclear leucocytes.
Jagodzinski P; Lizakowski S; Smolenski RT; Slominska EM; Goldsmith D; Simmonds HA; Rutkowski B
Clin Sci (Lond); 2004 Jul; 107(1):69-74. PubMed ID: 14723603
[TBL] [Abstract][Full Text] [Related]
40. The proton pump inhibitor pantoprazole and its interaction with enteric-coated mycophenolate sodium in transplant recipients.
Kofler S; Wolf C; Shvets N; Sisic Z; Müller T; Behr J; Sohn HY; Vogeser M; Shipkova M; Meiser B; Steinbeck G; Reichart B; Kaczmarek I
J Heart Lung Transplant; 2011 May; 30(5):565-71. PubMed ID: 21256049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
